22 "Lung Disease" clinical trials found.

• 

  Determination of B-cell responsiveness to the incretin hormones GLP-1 and GIP in Cystic Fibrosis (PRIME)

  The mechanisms underlying cystic fibrosis related diabetes (CFRD) pathophysiology must be better defined if care for people with CFRD is ...

• 

  An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

  This is a Phase 3a, extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension ...

  Harold Palevsky Md

• 

  Pilot study for functional and structural MR Imaging of Endobroncial valve recipients using hyperpoloarized XENON-129

  We propose to use gas Magnetic Resonance Imaging (MRI) using the inhaled contrast agent, hyperpolarized (HP) xenon-129, to study the ...

  Maurizio Cereda

• 

  Attain StarFix Model 4195 LV Lead Extraction Study

  The purpose of this study is to characterize the removability of the Attain StarFix®Model 4195 Left Ventricular (LV) Lead ...

  Robert Schaller

• 

  Intraoperative molecular imaging of pulmonary nodules by BY SGM-101

  Sunil Singhal Md

• 

  A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AEROVANC FOR THE TREATMENT OF PERSISTANT METHICILLIN-RESISTANT Staphylococcus aureus LUNG INFECTION IN ...

  TBD

• 

  Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer

  Surgery is the best treatment for patients with Stage I or II lung cancer; however, nearly 60% of patients have ...

  Sunil Singhal Md Charuhas Deshpande Lydia Frenzel Sulyok

• “The Shift Worker’s Microbiome”

  We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per ...

  Lavenia M Banas, Rn

• UPCC 09517: Phase II study of Pembrolizumab and Itacitinib (INCB039110) for First Line Treatment of Metastatic Non-Small Cell Lung Cancer ...

  The main purpose of this study is to examine the efficacy of adding itacitinib (also known as INCB039110) to pembrolizumab ...

  Joshua Bauml

• UPCC 06518: A Phase 2 Precision Oncology Study of Biomarker-Directed Pembrolizumab-Based Combination Therapy for Advanced Non-Small Cell Lung Cancer

  To evaluate the clinical activity (as assessed by objective response rate [ORR]) pembrolizumab (MK-3475) in combination with MK-4280 or lenvatinib ...

  Charu Aggarwal